215 related articles for article (PubMed ID: 26043944)
1. Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases.
Partelli S; Inama M; Rinke A; Begum N; Valente R; Fendrich V; Tamburrino D; Keck T; Caplin ME; Bartsch D; Thirlwell C; Fusai G; Falconi M
Neuroendocrinology; 2015; 102(1-2):68-76. PubMed ID: 26043944
[TBL] [Abstract][Full Text] [Related]
2. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.
Spolverato G; Bagante F; Aldrighetti L; Poultsides G; Bauer TW; Field RC; Marques HP; Weiss M; Maithel SK; Pawlik TM
J Gastrointest Surg; 2017 Dec; 21(12):2039-2047. PubMed ID: 28744737
[TBL] [Abstract][Full Text] [Related]
6. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach.
Bertani E; Fazio N; Botteri E; Chiappa A; Falconi M; Grana C; Bodei L; Papis D; Spada F; Bazolli B; Andreoni B
Surgery; 2014 Apr; 155(4):607-14. PubMed ID: 24582492
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
[TBL] [Abstract][Full Text] [Related]
8. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Sichinohe T
Hepatogastroenterology; 2012; 59(120):2623-6. PubMed ID: 22497945
[TBL] [Abstract][Full Text] [Related]
10. Extended surgery for advanced pancreatic endocrine tumours.
Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
[TBL] [Abstract][Full Text] [Related]
11. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
Ye H; Xu HL; Shen Q; Zheng Q; Chen P
J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
[TBL] [Abstract][Full Text] [Related]
12. Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence.
Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Dillhoff M; Maithel SK; Pawlik TM
HPB (Oxford); 2020 Feb; 22(2):215-223. PubMed ID: 31235429
[TBL] [Abstract][Full Text] [Related]
13. Treatment of liver metastases in patients with neuroendocrine tumors.
Frilling A; Rogiers X; Malagó M; Liedke OM; Kaun M; Broelsch CE
Langenbecks Arch Surg; 1998 Mar; 383(1):62-70. PubMed ID: 9627173
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
[TBL] [Abstract][Full Text] [Related]
15. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.
Chakedis J; Beal EW; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Marincola-Smith P; Cho C; Beems M; Pawlik TM; Maithel SK; Schmidt CR; Dillhoff M
J Gastrointest Surg; 2019 Jan; 23(1):122-134. PubMed ID: 30334178
[TBL] [Abstract][Full Text] [Related]
16. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
Zhang IY; Zhao J; Fernandez-Del Castillo C; Braun Y; Razmdjou S; Warshaw AL; Lillemoe KD; Ferrone CR
J Gastrointest Surg; 2016 Feb; 20(2):277-83. PubMed ID: 26691146
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study.
Sham JG; Ejaz A; Gage MM; Bagante F; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss MJ; Marques HP; Aldrighetti L; Pawlik TM; He J
J Gastrointest Surg; 2019 Mar; 23(3):484-491. PubMed ID: 29980977
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors.
Boyar Cetinkaya R; Vatn M; Aabakken L; Bergestuen DS; Thiis-Evensen E
Scand J Gastroenterol; 2014 Jun; 49(6):734-41. PubMed ID: 24679166
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of laparoscopic surgery for pancreatic neuroendocrine tumors.
Haugvik SP; Marangos IP; Røsok BI; Pomianowska E; Gladhaug IP; Mathisen O; Edwin B
World J Surg; 2013 Mar; 37(3):582-90. PubMed ID: 23263686
[TBL] [Abstract][Full Text] [Related]
20. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
